Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study
2024 · Journal of Clinical Oncology · 70 citations
https://doi.org/10.1200/jco.23.02736